BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 27 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,636,827 | +9.9% | 39,812,000 | +11.5% | 0.92% | +32.1% |
| Q2 2023 | $36,062,832 | +36.4% | 35,695,000 | +41.5% | 0.70% | +39.6% |
| Q1 2023 | $26,430,712 | -23.6% | 25,220,000 | -21.3% | 0.50% | -16.8% |
| Q4 2022 | $34,615,044 | +3.4% | 32,064,000 | -4.4% | 0.60% | -1.0% |
| Q3 2022 | $33,470,000 | -10.7% | 33,534,000 | -10.6% | 0.61% | -8.4% |
| Q2 2022 | $37,482,000 | -17.3% | 37,527,000 | -16.8% | 0.66% | -8.6% |
| Q1 2022 | $45,311,000 | -0.2% | 45,103,000 | +3.7% | 0.72% | -5.0% |
| Q4 2021 | $45,390,000 | -35.1% | 43,505,000 | -38.2% | 0.76% | -41.1% |
| Q3 2021 | $69,985,000 | -1.7% | 70,371,000 | -0.4% | 1.30% | -6.5% |
| Q2 2021 | $71,212,000 | – | 70,652,000 | – | 1.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT CAPITAL MANAGEMENT /DE/ | 70,652,000 | $71,212,000 | 1.38% |
| SHENKMAN CAPITAL MANAGEMENT INC | 14,821,000 | $14,947,000 | 1.36% |
| AQR Arbitrage LLC | 21,650,000 | $21,800,000 | 0.61% |
| Worth Venture Partners, LLC | 708,000 | $714,000 | 0.27% |
| LOOMIS SAYLES & CO L P | 2,366,716 | $197,478,000 | 0.24% |
| MACKAY SHIELDS LLC | 24,500,000 | $24,670,000 | 0.23% |
| CAMDEN ASSET MANAGEMENT L P /CA | 2,500,000 | $2,505,000 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,429,000 | $2,442,000 | 0.06% |
| Alberta Investment Management Corp | 5,500,000 | $5,545,000 | 0.05% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,900,000 | $1,913,000 | 0.04% |